Regina Leung is CEO of SylamoreBio, a biotechnology company developing a CNS delivery platform technology with a pipeline of rare disease programs. She is a healthcare executive based in the San Francisco Bay Area with over 25 years of leadership and business management experience in the life sciences industry, having held commercial roles at Bristol-Myers Squibb, Gilead Sciences, and McKesson.
Prior to joining SylamoreBio, she consulted for biopharmaceutical, private equity, and early-stage companies on projects spanning market access, commercial launches, due diligence, corporate valuation, capital raising, and strategic and licensing partnerships.